Recent advances in the management of AL Amyloidosis

Summary Immunoglobulin light chain (AL) amyloidosis, the most common of the systemic amyloidosis, is characterized by the deposition of amyloid fibrils that derive from the aggregation of misfolded monoclonal immunoglobulin light chains. Amyloid fibrils disrupt tissue architecture and the pre‐fibril...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	British journal of haematology Ročník 172; číslo 2; s. 170 - 186
Hlavní autori:	Kastritis, Efstathios, Dimopoulos, Meletios A.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England 01.01.2016
Predmet:	Amyloidosis - diagnosis Amyloidosis - immunology Amyloidosis - therapy heart failure Humans Immunoglobulin Light Chains - metabolism Immunoglobulin Light-chain Amyloidosis immunoglobulins light chains mass spectrometry Melphalan - therapeutic use monoclonal antibodies Myeloablative Agonists - therapeutic use Plasma Cells - drug effects Plasma Cells - pathology Risk Assessment - methods Stem Cell Transplantation - methods Treatment Outcome heart failure mass spectrometry light chains immunoglobulins monoclonal antibodies
ISSN:	0007-1048, 1365-2141, 1365-2141
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!